What does Michigan collateral support change for a manufacturer?
Michigan's Collateral Support Program can address a collateral shortfall identified by a lender by placing cash collateral with that lender. It supports a financing conversation; it is not a grant paid into the manufacturer's operating account and does not guarantee credit approval.
The MEDC lender overview explains the state's loan-enhancement routes. For an expanding manufacturer, the useful first question is whether the lender has identified a collateral gap, a cash-flow concern, or a different unresolved issue. Those findings lead to different conversations.
Collateral support is a lender-led mechanism
The official Collateral Support Program fact sheet describes a business engaged with a private lender, the lender's analysis of the shortfall, and a request for support through MEDC. If approved, the Michigan Strategic Fund deposits cash in an account at the lender, pledged as collateral on the borrower's behalf.
That cash supports the credit structure. It is not extra unrestricted working capital. The manufacturer still needs a financing decision, the actual loan documents, and answers to the requirements applicable to its request.
Follow the evidence through the process
- Manufacturer describes the project. Equipment, facility, and operating needs are supported with the appropriate records.
- Lender evaluates the credit. The lender identifies the issue rather than the owner guessing it.
- Specific shortfall is recorded. Collateral and cash-flow concerns are kept separate.
- Lender explores MEDC support. The applicable program and current requirements are confirmed.
- Program decision is made. A request is not an approval.
- Financing documents and next obligations are reviewed. The parties confirm their responsibilities and follow-through.
This process map is a plain-language organizational framework. It deliberately does not calculate support for a particular loan or certify that a lender's analysis satisfies program requirements.
Distinguish the neighboring loan-enhancement tools
| Tool | Mechanism described by MEDC | Question to ask |
|---|---|---|
| Collateral Support | Cash collateral for a lender-identified shortfall | Has the lender identified a collateral gap? |
| Loan Participation | Program purchases part of the lender's loan | Is the issue a cash-flow or lender-exposure concern? |
| Capital Access | A pooled loan-loss reserve mechanism | Which participating route is being discussed? |
| Loan Guarantee | Partial credit guarantee to a lender | Do the lender and borrower fit that separate route? |
The distinctions come from the official lender program table. Do not use “SSBCI loan” as though it describes one standard product.
MEDC's Loan Participation fact sheet describes purchase of part of a loan and reliance on the lead lender's analysis. That is different from a pledged collateral account. A support percentage or possible feature on a program page is not the terms of an offer to your business.
Which providers should a manufacturer contact?
Begin with the business's lender and the current MEDC capital-access contact. The collateral-support fact sheet lists participating financial institutions, including banks, credit unions, community lenders, and Farm Credit participants. Treat that list as a starting point to confirm current participation, not as a ranked directory of lenders willing to approve every manufacturing request.
A manufacturer can also use the broader equipment financing provider guide when it needs an asset-focused inquiry. Keep each provider's proposed product and the actual reason for an unresolved decision visible.
Build a shortfall evidence pack, not a sales pitch
| Section | Include | Avoid |
|---|---|---|
| Project | What is being purchased and why | An unsupported growth claim |
| Costs | Quotes, installation scope, dates | A total without line-item sources |
| Lender response | Original explanation and requested information | Owner-inferred eligibility |
| Asset evidence | Records requested by the lender | A self-created collateral valuation |
| Operating evidence | Requested financial records and labeled forecasts | Forecasts presented as actual results |
| Open questions | Named owner and next action | A support request recorded as approval |
Use the lender's checklist for sensitive records and submission channels. This preparation worksheet does not replace underwriting or professional valuation.
Worked example: a machine purchase with a reported gap
Imagine an illustrative Michigan manufacturer discussing a $500,000 equipment project. Its lender reports a $90,000 collateral gap and asks for additional records. Those are example figures, not a statement of qualification or a support calculation.
The owner records the lender's exact finding, the supplier quote, and outstanding asset documents. The lender can discuss whether Collateral Support is relevant. If the lender later identifies a separate concern about projected cash receipts, the team records that as another issue rather than assuming collateral support solves it.
The project log distinguishes “lender reviewing,” “support route being discussed,” “support requested,” and “decision received.” No stage is advanced simply because an owner has found a state program page.
Keep lender context and follow-through together
Finta CRM connects the lender, supplier, and adviser with next actions. Keep approved materials in Documents and use Aurora to help prepare a concise evidence brief. The funding-response review workflow starts from the actual provider message; the equipment-quote workflow preserves the proposed asset and terms.
Methodology and limits
Finta Editorial Team reviewed the official MEDC lender page and linked fact sheets on October 1, 2026, U.S. Eastern time. No current allocation balance, approval probability, or personalized support amount is asserted. Participation and program requirements must be confirmed with MEDC and the lender. This is factual mechanism education and organizational guidance, not individualized financial or eligibility advice.